Speciality Active Pharmaceutical Ingredients (APIs)
Specialty Active Pharmaceutical Ingredients (APIs) represent a critical segment of the pharmaceutical supply chain, comprising biologically active compounds designed to deliver targeted therapeutic effects. At Nexmida, we specialize in global supply of high-quality Specialty APIs, including Oncology, Anti-diabetic, and CNS (Central Nervous System) categories, manufactured to meet the most stringent international purity and regulatory standards. Our APIs are tailored for the US and EU markets, ensuring full compliance with US FDA, EMA, and WHO guidelines.
By consistently delivering pharmaceutically graded, high-purity APIs, we enable our partners worldwide to produce effective, safe, and reliable therapies that improve patient outcomes
Oncology APIs
Oncology APIs are high-precision engineered ingredients used in cancer treatment formulations that target specific molecular pathways involved in tumour growth. Our portfolio includes Methotrexate, produced to ≥99% purity and optimized for stability and therapeutic performance, enabling global manufacturers to deliver effective and reliable cancer therapeutics.
CNS (Central Nervous System) APIs
Central Nervous System (CNS) APIs are active pharmaceutical ingredients formulated to treat neurological and psychiatric disorders such as depression, epilepsy, Parkinson’s disease, and anxiety. We supply high-quality CNS APIs including Gabapentin, produced to pharmaceutical-grade purity and validated through multi-stage quality testing for safety and efficacy.
Anti-diabetic APIs
Anti-diabetic APIs are specialized active pharmaceutical ingredients used in the formulation of medications that help regulate blood glucose levels and manage diabetes effectively. At Nexmida, we supply high-quality Anti-diabetic APIs such as Metformin, manufactured under strict cGMP conditions to ensure superior consistency and bioavailability. These APIs support the formulation of oral and injectable therapies for effective diabetes management